Water → HCID 59334933, compound
Reaction equation
[CH2:1]([NH:8][C:9]([N:11]1[C:19]2[C:14](=[CH:15][C:16]([NH:20][S:21]([C:24]3[CH:29]=[C:28]([Cl:30])[CH:27]=[C:26]([Cl:31])[CH:25]=3)(=[O:23])=[O:22])=[CH:17][CH:18]=2)[CH:13]=[CH:12]1)=[O:10])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1.C(=O)([O-])[O-].[K+].[K+].Br[CH2:39][C:40]([O:42][C:43]([CH3:46])([CH3:45])[CH3:44])=[O:41].O>CN(C)C=O.C(OCC)(=O)C>[CH2:1]([NH:8][C:9]([N:11]1[C:19]2[C:14](=[CH:15][C:16]([N:20]([CH2:39][C:40]([O:42][C:43]([CH3:46])([CH3:45])[CH3:44])=[O:41])[S:21]([C:24]3[CH:29]=[C:28]([Cl:30])[CH:27]=[C:26]([Cl:31])[CH:25]=3)(=[O:23])=[O:22])=[CH:17][CH:18]=2)[CH:13]=[CH:12]1)=[O:10])[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1Participants
7
Procedure
150 mg 5-(3,5-dichloro-phenylsulphonylamino)-indole-1-carboxylic acid-benzylamide are dissolved in 5 ml dimethylformamide. 109 mg potassium carbonate and 51 μl tert.butyl bromoacetate are added thereto. The mixture is stirred for 4 hours at ambient temperature, the solvent is eliminated in vacuo and the residue is divided between water and ethyl acetate. The aqueous phase is extracted with ethyl acetate and the combined organic phases are dried on magnesium sulphate. The solvents are eliminated in vacuo and the residue is purified by chromatography on silica gel (cyclohexane/ethyl acetate 10:1 to 1:3).
Workup
- extractionThe aqueous phase is extracted with ethyl acetate
- customthe combined organic phases are dried on magnesium sulphate
- customthe residue is purified by chromatography on silica gel (cyclohexane/ethyl acetate 10:1 to 1:3)
Sources & evidence
- ORD record
- ord-e7cdc965aec540cb805e36417885b0e4
- Source dataset
- uspto-grants-2012_07
- Patent number
- US08232312B2
Reaction notes
Loading…